Your expecting no difference between treatment arm and placebo?? If that were the case, the study would have been stopped during the mid point review. It would have been clear that the primary endpoint could not have been statistically significant and study terminated. You think they just wanted to pay millions for study completion to issue data that was evident at mid point??